全文获取类型
收费全文 | 12092篇 |
免费 | 886篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 87篇 |
儿科学 | 374篇 |
妇产科学 | 317篇 |
基础医学 | 1708篇 |
口腔科学 | 269篇 |
临床医学 | 1422篇 |
内科学 | 2491篇 |
皮肤病学 | 325篇 |
神经病学 | 1227篇 |
特种医学 | 216篇 |
外科学 | 1017篇 |
综合类 | 78篇 |
一般理论 | 16篇 |
预防医学 | 1443篇 |
眼科学 | 238篇 |
药学 | 831篇 |
中国医学 | 46篇 |
肿瘤学 | 920篇 |
出版年
2023年 | 128篇 |
2022年 | 205篇 |
2021年 | 496篇 |
2020年 | 285篇 |
2019年 | 380篇 |
2018年 | 401篇 |
2017年 | 297篇 |
2016年 | 360篇 |
2015年 | 360篇 |
2014年 | 460篇 |
2013年 | 653篇 |
2012年 | 947篇 |
2011年 | 965篇 |
2010年 | 538篇 |
2009年 | 448篇 |
2008年 | 762篇 |
2007年 | 749篇 |
2006年 | 702篇 |
2005年 | 689篇 |
2004年 | 589篇 |
2003年 | 593篇 |
2002年 | 513篇 |
2001年 | 61篇 |
2000年 | 51篇 |
1999年 | 53篇 |
1998年 | 97篇 |
1997年 | 92篇 |
1996年 | 91篇 |
1995年 | 71篇 |
1994年 | 61篇 |
1993年 | 61篇 |
1992年 | 38篇 |
1991年 | 46篇 |
1990年 | 31篇 |
1989年 | 32篇 |
1988年 | 37篇 |
1987年 | 34篇 |
1986年 | 33篇 |
1985年 | 32篇 |
1984年 | 37篇 |
1983年 | 44篇 |
1982年 | 42篇 |
1981年 | 41篇 |
1980年 | 48篇 |
1979年 | 15篇 |
1978年 | 21篇 |
1977年 | 26篇 |
1975年 | 16篇 |
1974年 | 15篇 |
1973年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
133.
Ken Fukunaga Yoshio Ohda Nobuyuki Hida Masaki Iimuro Yoko Yokoyama Koji Kamikozuru Kazuko Nagase Shiro Nakamura Hiroto Miwa Takayuki Matsumoto 《Journal of gastroenterology and hepatology》2012,27(12):1808-1815
Background and Aim: Topical mesalamine or corticosteroid has shown efficacy in patients with ulcerative proctitis, but patients often become refractory to these interventions. Xilei San is a herbal preparation with evidence of anti‐inflammatory effects. We evaluated the efficacy of topical Xilei San in ulcerative proctitis patients. Methods: In a double blind setting, 30 patients with intractable ulcerative proctitis despite ≥ 4 weeks of topical mesalamine or corticosteroid were randomly assigned to True (n = 15) and placebo (n = 15). Patients in True received suppository Xilei San (0.1 g/dose per day of Xilei San), the other 15 received placebo suppository. The initial efficacy was evaluated on day 14. Primary endpoint of the trial was avoiding relapse during 180 days, relapse meant recurrence of active disease. Riley's index was applied for endoscopic and histological evaluations, while patients' quality of life was evaluated by an inflammatory bowel disease questionnaire. Results: On day 14, the number of patients who achieved remission, clinical activity index ≤ 4 in True was significantly higher versus placebo (P < 0.04). Likewise, at day 180, an 81.8% of patients in True were without relapse versus 16.7% in placebo (P < 0.001). Further, significant endoscopic (P < 0.01), histological (P < 0.02) and inflammatory bowel disease questionnaire (P < 0.04) improvements were observed in True, but not in placebo. Conclusions: This is the first controlled investigation showing significant clinical and endoscopic efficacy for Xilei San in patients with intractable ulcerative proctitis. Topical Xilei San was well tolerated, and was without safety concerns. 相似文献
134.
Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis are leading causes of vaccine-preventable diseases such as meningitis, sepsis and pneumonia. Although there has been much progress in the introduction of vaccines against these pathogens, access to vaccines remains elusive in some countries. This review highlights the current S. pneumoniae, H. influenzae type b, and N. meningitidis immunization schedules in the 10 countries belonging to the Association of Southeast Asian Nations (ASEAN). Epidemiologic studies may be useful for informing vaccine policy in these countries, particularly when determining the cost-effectiveness of introducing new vaccines. 相似文献
135.
136.
137.
Perinatal outcomes among young Indigenous Australian mothers: A cross‐sectional study and comparison with adult Indigenous mothers
下载免费PDF全文
![点击此处可从《分娩》网站下载免费的PDF全文](/ch/ext_images/free.gif)
138.
139.